Phase 2 study
Clinical trials for Phase 2 study explained in plain language.
Never miss a new study
Get alerted when new Phase 2 study trials appear
Sign up with your email to follow new studies for Phase 2 study, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo targets Hard-to-Treat pancreatic cancer
Disease control Recruiting nowThis study tests whether adding the drug BMS-986504 to standard chemotherapy can help control pancreatic cancer in people with a specific genetic change (MTAP deletion). About 60 adults with this type of pancreatic cancer will receive the combination before and after surgery or w…
Matched conditions: PHASE 2 STUDY
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
New hope for aggressive lymphoma: drug cocktail aims to control High-Risk MCL
Disease control Recruiting nowThis phase 2 trial is testing whether adding the drug glofitamab after an initial treatment with acalabrutinib (or zanubrutinib) and rituximab can better control high-risk mantle cell lymphoma (MCL) in people who have not been treated before. The study will enroll 30 participants…
Matched conditions: PHASE 2 STUDY
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC